Login

TAY TWO CO., LTD., based in West Japan, is a comprehensive second-hand retail company focused on reselling pre-owned goods. 00:10:00

Share On Facebook Share On Twitter

Yasuyoshi Mitsumoto is Board Member at Tay Two Co Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
De Belegger on Tour - Pitch with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck
00:10:00
2023 HY Results Discussion: CEO and CFO Insights | Rob Wood - CEO of Breedon Group
00:10:00
The Journey of Steve Diggle and Artradis Fund Management to Vulpes Investment Management | Steve Diggle, Co-founder , Artradis Fund Management
00:10:00
West Red Lake Gold Mines Gears Up for Gold Production at Madsen Mine|Gwen Preston,Vice President, Communications,West Red Lake Gold Mines Ltd
00:10:00
In this 5-minute Q&A, we speak with Neal Barclay, CEO of Meridian Energy, following his presentation at our Investor Day event.
00:10:00
Senior Resources: High-Grade Gold Opportunities in British Columbia's Golden Triangle
00:10:00
Canadian North Resources Reports Exciting Drilling Results and Expanding Resource Potential
00:10:00
M2Bio Sciences & Juvenescence - 7. The Potential of the Medical Psychedelics | Rob Schwartz, CEO, Anterix IncATEX:NAQ
00:00:00
Görgen Nilsson, CEO, ScandiDos
00:10:00
Timberline Resources' Carlin-Style Eureka Project Hits High-Grade Gold Intersections
00:10:00
Ronald Thiessen Discusses Northern Dynasty's World-Class Pebble Project and Copper's Future
00:10:00
Current Trends and Future Prospects in the Global Thermal Coal Market: Insights from 2018 to Long-Term Demand Dynamics

© 2017 - Neuhu+